Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

Specimen Processing and Biobanking Services

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract for Specimen Processing and Biobanking Services supports Department of Defense breast cancer research projects by managing the collection, storage, and processing of biological specimens. The provider is responsible for processing blood and breast cancer tissue using specialized equipment, including centrifuges, ultra-low temperature freezers, and Laboratory Information Management Systems, while ensuring all operations adhere to CLIA certification and Biosafety Level standards. The contract is managed under the Defense Health Agency Contracting Activity with a NAICS code of 541380. The solicitation was posted on September 3, 2026, with a response deadline of November 18, 2026. The primary objective is the delivery of high-quality processed and archived biological specimens to prime contractors.

General Info

Subcontract for DoD breast cancer research involving specimen processing and biobanking services.

Agency

Department Of Defense → Defense Health Agency Contracting Activity - DhacaView Agency

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

Not specified

Set-Aside

NONE

Documents

This scope was carved out of HT942526BCRPCREA2.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Breast Cancer, Clinical Research Extension Award

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency Contracting Activity - Dhaca
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → Defense Health Agency Contracting Activity - Dhaca
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies and manages collection, storage, and processing of biological specimens for prime contractors on Department of Defense breast cancer research projects. Processes breast cancer tissue and blood specimens using ultra-low temperature freezers (-80°C), centrifuges, and LIMS. Adheres to CLIA certification and Biosafety Level (BSL) standards. Delivers processed and archived biological specimens.

Similar Contracts

Same NAICS industry code

NAICS: 541380
New
Federal
New Car Assessment Program (NCAP) Pedestrian Impact Testing
Solicitation # 693JJ926R000073
The National Highway Traffic Safety Administration (NHTSA) is seeking a multiple-award Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract for pedestrian protection impact testing on production motor vehicles as part of the New Car Assessment Program (NCAP). The selected contractors will perform test-procedure evaluations, impactor qualifications for headforms, Flexible Pedestrian Legform Impactors (Flex-PLI), and upper legforms, as well as actual testing on assigned vehicle models. These services, which may include optional cyclist and aPLI testing, must be conducted at the contractor's off-site facility in Washington, DC, in accordance with the NCAP Crashworthiness Pedestrian Protection Test Procedure. The contract will be structured as a firm-fixed-price agreement with five 12-month ordering periods, including options to extend services for up to six months and options for increased quantities. Award decisions will be based on a best-value tradeoff, where technical factors—including the technical plan, quality assurance management plan, facilities, personnel qualifications, and past performance—are collectively more important than price. This full and open competition falls under NAICS code 541380. The formal request for proposals is expected to be posted on SAM.gov around August 28, 2026, with a submission deadline of September 14, 2026.
693JJ9 Nhtsa Office Of Acquistion

POSTED

1 day ago

DEADLINE

in 9 days
View Details

More opportunities from Department Of Defense → Defense Health Agency Contracting Activity - Dhaca

Same awarding agency

NAICS: 541715
New
Grant
DoW Breast Cancer, Breakthrough Award Levels 1 and 2
Solicitation # HT942526BCRPBTA122
The Department of Defense, through the Defense Health Agency Contracting Activity, is soliciting applications for the Fiscal Year 2026 Breast Cancer Research Program Breakthrough Award Levels 1 and 2 under solicitation number HT942526BCRPBTA122. This mechanism is designed to support high-potential research aimed at achieving breakthroughs in breast cancer, requiring all applications to address at least one overarching FY26 BCRP challenge or provide a strong justification for an exception. The program offers two funding levels with distinct research scopes, including a Population Science Studies option under Level 2 that may allow for increased funding and an extended period of performance. Eligible applicants may apply as a single Principal Investigator or through a partnering arrangement involving an Initiating PI and a Partnering PI. The application process follows a two-step sequence, with pre-applications due by November 4, 2026, and full applications due by November 18, 2026. For those utilizing the Partnering PI Option, both investigators must submit full applications to avoid administrative withdrawal. The program emphasizes a focus on research that can lead to clinical application and major impact, with all submissions governed by specific registration and review criteria managed by the grantor.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

4 days ago

DEADLINE

in 2 months
View Details